Lazarovici, J., Amorim, S., Bouabdallah, K., Fournier, M., Guidez, S., Molina, L., Morschhauser, F., Delapierre, B., Gastinne, T., Laribi, K., Launay, V., Slama, B., Belmecheri, N., Casasnovas, R.-O., Corby, A., Durot, E., Feugier, P., Nicolas-Virelizie, E., Sibon, D., Berriolo-Riedinger, A., Edeline, V., Borght, T. V., Damotte, D., Traverse-Glehen, A., Ribrag, V. and André, M. (2020) “Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa study”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.300166.